Design and optimization of camptothecin conjugates of triple helix-forming oligonucleotides for sequence-specific DNA cleavage by topoisomerase I

Paola B. Arimondo, Alexandre Boutorine, Brigitte Baldeyrou, Christian Bailly, Masayasu Kuwahara, Sidney Hecht, Jian Sheng Sun, Thérèse Garestier, Claude Hélène

Research output: Contribution to journalArticle

47 Citations (Scopus)

Abstract

To achieve a sequence-specific DNA cleavage by topoisomerase I, derivatives of the antitumor drug camptothecin have been covalently linked to triple helix-forming oligonucleotides that bind in a sequence-specific manner to the major groove of double-helical DNA. Triplex formation at the target sequence positions the drug selectively at the triplex site, thereby stimulating topoisomerase I-mediated DNA cleavage at this site. In a continuous effort to optimize this strategy, a broad set of conjugates consisting of (i) 16-20-base-long oligonucleotides, (ii) alkyl linkers of variable length, and (iii) camptothecin derivatives substituted on the A or B quinoline ring were designed and synthesized. Analysis of the cleavage sites at nucleotide resolution reveals that the specificity and efficacy of cleavage depends markedly on the length of both the triple-helical structure and the linker between the oligonucleotide and the poison. The optimized hybrid molecules induced strong and highly specific cleavage at a site adjacent to the triplex. Furthermore, the drug-stabilized DNA-topoisomerase I cleavage complexes were shown to be more resistant to salt-induced reversal than the complexes induced by camptothecin alone. Such rationally designed camptothecin conjugates could provide useful antitumor drugs directed selectively against genes bearing the targeted triplex binding site. In addition, they represent a powerful tool to probe the molecular interactions in the DNA-topoisomerase I complex.

Original languageEnglish (US)
Pages (from-to)3132-3140
Number of pages9
JournalJournal of Biological Chemistry
Volume277
Issue number5
DOIs
StatePublished - Feb 1 2002
Externally publishedYes

Fingerprint

Camptothecin
Type I DNA Topoisomerase
DNA Cleavage
Oligonucleotides
DNA
Antineoplastic Agents
Bearings (structural)
Derivatives
Molecular Probes
Molecular interactions
Poisons
Pharmaceutical Preparations
Nucleotides
Salts
Genes
Binding Sites
Molecules

ASJC Scopus subject areas

  • Biochemistry

Cite this

Design and optimization of camptothecin conjugates of triple helix-forming oligonucleotides for sequence-specific DNA cleavage by topoisomerase I. / Arimondo, Paola B.; Boutorine, Alexandre; Baldeyrou, Brigitte; Bailly, Christian; Kuwahara, Masayasu; Hecht, Sidney; Sun, Jian Sheng; Garestier, Thérèse; Hélène, Claude.

In: Journal of Biological Chemistry, Vol. 277, No. 5, 01.02.2002, p. 3132-3140.

Research output: Contribution to journalArticle

Arimondo, Paola B. ; Boutorine, Alexandre ; Baldeyrou, Brigitte ; Bailly, Christian ; Kuwahara, Masayasu ; Hecht, Sidney ; Sun, Jian Sheng ; Garestier, Thérèse ; Hélène, Claude. / Design and optimization of camptothecin conjugates of triple helix-forming oligonucleotides for sequence-specific DNA cleavage by topoisomerase I. In: Journal of Biological Chemistry. 2002 ; Vol. 277, No. 5. pp. 3132-3140.
@article{580bc10c44f341f495d618d0d0f31358,
title = "Design and optimization of camptothecin conjugates of triple helix-forming oligonucleotides for sequence-specific DNA cleavage by topoisomerase I",
abstract = "To achieve a sequence-specific DNA cleavage by topoisomerase I, derivatives of the antitumor drug camptothecin have been covalently linked to triple helix-forming oligonucleotides that bind in a sequence-specific manner to the major groove of double-helical DNA. Triplex formation at the target sequence positions the drug selectively at the triplex site, thereby stimulating topoisomerase I-mediated DNA cleavage at this site. In a continuous effort to optimize this strategy, a broad set of conjugates consisting of (i) 16-20-base-long oligonucleotides, (ii) alkyl linkers of variable length, and (iii) camptothecin derivatives substituted on the A or B quinoline ring were designed and synthesized. Analysis of the cleavage sites at nucleotide resolution reveals that the specificity and efficacy of cleavage depends markedly on the length of both the triple-helical structure and the linker between the oligonucleotide and the poison. The optimized hybrid molecules induced strong and highly specific cleavage at a site adjacent to the triplex. Furthermore, the drug-stabilized DNA-topoisomerase I cleavage complexes were shown to be more resistant to salt-induced reversal than the complexes induced by camptothecin alone. Such rationally designed camptothecin conjugates could provide useful antitumor drugs directed selectively against genes bearing the targeted triplex binding site. In addition, they represent a powerful tool to probe the molecular interactions in the DNA-topoisomerase I complex.",
author = "Arimondo, {Paola B.} and Alexandre Boutorine and Brigitte Baldeyrou and Christian Bailly and Masayasu Kuwahara and Sidney Hecht and Sun, {Jian Sheng} and Th{\'e}r{\`e}se Garestier and Claude H{\'e}l{\`e}ne",
year = "2002",
month = "2",
day = "1",
doi = "10.1074/jbc.M110181200",
language = "English (US)",
volume = "277",
pages = "3132--3140",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "5",

}

TY - JOUR

T1 - Design and optimization of camptothecin conjugates of triple helix-forming oligonucleotides for sequence-specific DNA cleavage by topoisomerase I

AU - Arimondo, Paola B.

AU - Boutorine, Alexandre

AU - Baldeyrou, Brigitte

AU - Bailly, Christian

AU - Kuwahara, Masayasu

AU - Hecht, Sidney

AU - Sun, Jian Sheng

AU - Garestier, Thérèse

AU - Hélène, Claude

PY - 2002/2/1

Y1 - 2002/2/1

N2 - To achieve a sequence-specific DNA cleavage by topoisomerase I, derivatives of the antitumor drug camptothecin have been covalently linked to triple helix-forming oligonucleotides that bind in a sequence-specific manner to the major groove of double-helical DNA. Triplex formation at the target sequence positions the drug selectively at the triplex site, thereby stimulating topoisomerase I-mediated DNA cleavage at this site. In a continuous effort to optimize this strategy, a broad set of conjugates consisting of (i) 16-20-base-long oligonucleotides, (ii) alkyl linkers of variable length, and (iii) camptothecin derivatives substituted on the A or B quinoline ring were designed and synthesized. Analysis of the cleavage sites at nucleotide resolution reveals that the specificity and efficacy of cleavage depends markedly on the length of both the triple-helical structure and the linker between the oligonucleotide and the poison. The optimized hybrid molecules induced strong and highly specific cleavage at a site adjacent to the triplex. Furthermore, the drug-stabilized DNA-topoisomerase I cleavage complexes were shown to be more resistant to salt-induced reversal than the complexes induced by camptothecin alone. Such rationally designed camptothecin conjugates could provide useful antitumor drugs directed selectively against genes bearing the targeted triplex binding site. In addition, they represent a powerful tool to probe the molecular interactions in the DNA-topoisomerase I complex.

AB - To achieve a sequence-specific DNA cleavage by topoisomerase I, derivatives of the antitumor drug camptothecin have been covalently linked to triple helix-forming oligonucleotides that bind in a sequence-specific manner to the major groove of double-helical DNA. Triplex formation at the target sequence positions the drug selectively at the triplex site, thereby stimulating topoisomerase I-mediated DNA cleavage at this site. In a continuous effort to optimize this strategy, a broad set of conjugates consisting of (i) 16-20-base-long oligonucleotides, (ii) alkyl linkers of variable length, and (iii) camptothecin derivatives substituted on the A or B quinoline ring were designed and synthesized. Analysis of the cleavage sites at nucleotide resolution reveals that the specificity and efficacy of cleavage depends markedly on the length of both the triple-helical structure and the linker between the oligonucleotide and the poison. The optimized hybrid molecules induced strong and highly specific cleavage at a site adjacent to the triplex. Furthermore, the drug-stabilized DNA-topoisomerase I cleavage complexes were shown to be more resistant to salt-induced reversal than the complexes induced by camptothecin alone. Such rationally designed camptothecin conjugates could provide useful antitumor drugs directed selectively against genes bearing the targeted triplex binding site. In addition, they represent a powerful tool to probe the molecular interactions in the DNA-topoisomerase I complex.

UR - http://www.scopus.com/inward/record.url?scp=0036479132&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036479132&partnerID=8YFLogxK

U2 - 10.1074/jbc.M110181200

DO - 10.1074/jbc.M110181200

M3 - Article

C2 - 11724801

AN - SCOPUS:0036479132

VL - 277

SP - 3132

EP - 3140

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 5

ER -